Jeremy Leipzig

Jeremy Leipzig

Auto-generated profile, based on publicly available information

Jeremy Leipzig

Center for Biomedical Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2013 in Nature
Verified
Journal Article
Open access
PDF file
SZSamir Zaidi
Samir Zaidi
MCMurim Choi
Murim Choi
HWHiroko Wakimoto
Hiroko Wakimoto
LMLijiang Ma
Lijiang Ma
JJJianming Jiang
Jianming Jiang
RLRichard P. Lifton
Richard P. Lifton
Exome sequencing of patients with congenital heart disease (CHD) and their unaffected parents reveals an excess of strong-effect, protein-altering de novo mutations in genes expressed in the developing heart, many of which regulate chromatin modification in key developmental genes; collectively, these mutations are predicted to account for approximately 10% of severe CHD cases. This paper demonstrates that de novo mutations with large effect have a role in the pathogenesis of at least 10% of cases of congenital heart disease (CHD). Using exome sequence analysis in parent–offspring trios Richard Lifton and colleagues compared the frequency of de novo mutations, identified by exome sequencing, in 362 CHD parent–offspring trios and 264 control trios. Gene ontology analysis demonstrated significant enrichment of de novo protein-altering mutation of genes involved in chromatin modification, notably a marked enrichment of genes involved in the production, removal and reading of methylation of histone H3K4 and H3K27. Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births1. Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent–offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation2,3,4. There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left–right organizer5. The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes ‘poised’ promoters and enhancers, which regulate expression of key developmental genes6. These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.

27 November 2005 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
Angela CiuffiAngela Ciuffi
Angela Ciuffi
MLManuel Llano
Manuel Llano
EPEric Poeschla
Eric Poeschla
CHChris Hoffmann
Chris Hoffmann
JLJeremy Leipzig
Jeremy Leipzig
FBFrederic Bushman
Frederic Bushman

12 December 2013 in Current Protocols in Bioinformatics
Verified
Journal Article
Open access
PDF file
MLMarie Lott
Marie Lott
JLJeremy N. Leipzig
Jeremy N. Leipzig
ODOlga Derbeneva
Olga Derbeneva
HXhongbo xie
hongbo xie
DCDimitra Chalkia
Dimitra Chalkia
DWDouglas C C. Wallace
Douglas C C. Wallace
The Mitomap database of human mitochondrial DNA (mtDNA) information has been an important compilation of mtDNA variation for researchers, clinicians, and genetic counselors for the past 25 years. The Mitomap protocol shows how users may look up human mitochondrial gene loci, search for public mitochondrial sequences, and browse or search for reported general population nucleotide variants as well as those reported in clinical disease. Within Mitomap is the powerful sequence analysis tool for human mitochondrial DNA, Mitomaster. The Mitomaster protocol gives step‐by‐step instructions showing how to submit sequences to identify nucleotide variants relative to the rCRS, determine the haplogroup, and view species conservation. User‐supplied sequences, GenBank identifiers, and single‐nucleotide variants may be analyzed. Curr. Protoc. Bioinform. 44:1.23.1‐1.23.26. © 2013 by John Wiley & Sons, Inc.

1 June 2007 in Genome Research
Verified
Journal Article
Closed access
PDF file
GWGary P. Wang
Gary P. Wang
Angela CiuffiAngela Ciuffi
Angela Ciuffi
JLJeremy Leipzig
Jeremy Leipzig
CBCharles C. Berry
Charles C. Berry
FBFrederic D. Bushman
Frederic D. Bushman
Integration of retroviral DNA into host cell DNA is a defining feature of retroviral replication. HIV integration is known to be favored in active transcription units, which promotes efficient transcription of the viral genes, but the molecular mechanisms responsible for targeting are not fully clarified. Here we used pyrosequencing to map 40,569 unique sites of HIV integration. Computational prediction of nucleosome positions in target DNA indicated that integration sites are periodically distributed on the nucleosome surface, consistent with favored integration into outward-facing DNA major grooves in chromatin. Analysis of integration site positions in the densely annotated ENCODE regions revealed a wealth of new associations between integration frequency and genomic features. Integration was particularly favored near transcription-associated histone modifications, including H3 acetylation, H4 acetylation, and H3 K4 methylation, but was disfavored in regions rich in transcription-inhibiting modifications, which include H3 K27 trimethylation and DNA CpG methylation. Statistical modeling indicated that effects of histone modification on HIV integration were partially independent of other genomic features influencing integration. The pyrosequencing and bioinformatic methods described here should be useful for investigating many aspects of retroviral DNA integration.

19 September 2005 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
FBFrederic Bushman
Frederic Bushman
MLMary Lewinski
Mary Lewinski
Angela CiuffiAngela Ciuffi
Angela Ciuffi
SBStephen Barr
Stephen Barr
JLJeremy Leipzig
Jeremy Leipzig
CHChris Hoffmann
Chris Hoffmann

23 June 2006 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MLMary K Lewinski
Mary K Lewinski
MYMasahiro Yamashita
Masahiro Yamashita
MEMichael Emerman
Michael Emerman
Angela CiuffiAngela Ciuffi
Angela Ciuffi
HMHeather Marshall
Heather Marshall
FBFrederic D Bushman
Frederic D Bushman
Retroviruses differ in their preferences for sites for viral DNA integration in the chromosomes of infected cells. Human immunodeficiency virus (HIV) integrates preferentially within active transcription units, whereas murine leukemia virus (MLV) integrates preferentially near transcription start sites and CpG islands. We investigated the viral determinants of integration-site selection using HIV chimeras with MLV genes substituted for their HIV counterparts. We found that transferring the MLV integrase (IN) coding region into HIV (to make HIVmIN) caused the hybrid to integrate with a specificity close to that of MLV. Addition of MLV gag (to make HIVmGagmIN) further increased the similarity of target-site selection to that of MLV. A chimeric virus with MLV Gag only (HIVmGag) displayed targeting preferences different from that of both HIV and MLV, further implicating Gag proteins in targeting as well as IN. We also report a genome-wide analysis indicating that MLV, but not HIV, favors integration near DNase I–hypersensitive sites (i.e., +/− 1 kb), and that HIVmIN and HIVmGagmIN also favored integration near these features. These findings reveal that IN is the principal viral determinant of integration specificity; they also reveal a new role for Gag-derived proteins, and strengthen models for integration targeting based on tethering of viral IN proteins to host proteins. A required step in the replication cycle of retroviruses is the integration of a DNA copy of the viral genome into a host cell chromosome. Recent studies have shown that human immunodeficiency virus (HIV) and murine leukemia virus (MLV) favor integration near different chromosomal features. HIV preferentially targets active genes, while MLV prefers integration near start sites of gene transcription. The authors investigated integration-target site–selection by HIV derivatives substituted with segments of MLV to determine which viral proteins are responsible for integration-targeting preferences. They found that the viral integrase protein is the dominant determinant of integration-site selection, probably through its tethering to cellular proteins bound near preferred genomic regions. In addition, components of the viral structural polyprotein, Gag, appear to be involved in targeting. These findings provide a functional map of the viral proteins involved in directing integration-site selection.